Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
BMC Cancer|September 1, 2016
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samplesSilvia Bonfiglio, Irene Vanni, Valeria Rossella, et al.Current Drug Targets|December 16, 2014
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicineSimona Coco, Anna Truini, Irene Vanni, et al.Cancer Chemotherapy and Pharmacology|February 22, 2012
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinibFrancesco Grossi, Erika Rijavec, Maria Giovanna Dal Bello, et al.Lung Cancer (Amsterdam, Netherlands)|May 8, 2013
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in ItalyFrancesco Grossi, Carlo Genova, Nidia Diaz Gaitan, et al.Targeted Oncology|October 25, 2014
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transitionSimona Coco, Anna Truini, Angela Alama, et al.Molecular Cancer|August 31, 2013
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patientsRoberto Puzone, Graziana Savarino, Sandra Salvi, et al.International Journal of Molecular Sciences|May 12, 2017
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line ChemotherapySimona Coco, Angela Alama, Irene Vanni, et al.International Journal of Molecular Sciences|December 4, 2015
Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ PlatformIrene Vanni, Simona Coco, Anna Truini, et al.Expert Opinion on Biological Therapy|July 28, 2015
Belagenpumatucel-L for the treatment of non-small cell lung cancerErika Rijavec, Federica Biello, Carlo Genova, et al.Journal of Clinical Medicine|July 13, 2019
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with NivolumabAngela Alama, Simona Coco, Carlo Genova, et al.Pageof 10